Concourse Financial Group Securities, Inc. Agile Therapeutics Inc Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$0.21 - $0.31 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023
BUY
$0.18 - $15.25 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022
BUY
$0.28 - $14.85 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
$1.09 - $8.24 $0 - $0
0 New
0 $0

About AGILE THERAPEUTICS INC

AGRX Quotes by TradingView
  • Ticker AGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 39,023,000
  • Description
  • Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line exte...
More about AGRX
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email